Stock Research for CYCC

Current Price


Latest Update: 2018-03-22 16:00:00

$ 1.4300
$ 1.4200
$ 1.4300

Featured Broker: TradeStation

Get the due diligence for another stock.


CYCC Stock Chart & Research Data

The CYCC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYCC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CYCC Due diligence Resources & Stock Charts

The CYCC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYCC Detailed Price Forecast - CNN Money CNN View CYCC Detailed Summary - Google Finance
Yahoo View CYCC Detailed Summary - Yahoo! Finance Zacks View CYCC Stock Research & Analysis -

Stock Analysis

TradeIdeas View CYCC Trends & Analysis - Trade-Ideas Barrons View CYCC Major Holders - Barrons
NASDAQ View CYCC Call Transcripts - NASDAQ Seeking View CYCC Breaking News & Analysis - Seeking Alpha
Spotlight View CYCC Annual Report - OTC Report View CYCC OTC Short Report -
TradeKing View CYCC Fundamentals - TradeKing Charts View CYCC SEC Filings - Bar Chart
WSJ View Historical Prices for CYCC - The WSJ Morningstar View Performance/Total Return for CYCC - Morningstar
MarketWatch View the Analyst Estimates for CYCC - MarketWatch CNBC View the Earnings History for CYCC - CNBC
StockMarketWatch View the CYCC Earnings - StockMarketWatch MacroAxis View CYCC Buy or Sell Recommendations - MacroAxis
Bullish View the CYCC Bullish Patterns - American Bulls Short Pains View CYCC Short Pain Metrics -

Social Media Mentions

StockTwits View CYCC Stock Mentions - StockTwits PennyStocks View CYCC Stock Mentions - PennyStockTweets
Twitter View CYCC Stock Mentions - Twitter Invest Hub View CYCC Investment Forum News - Investor Hub
Yahoo View CYCC Stock Mentions - Yahoo! Message Board Seeking Alpha View CYCC Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CYCC - Insider Cow View Insider Transactions for CYCC - Insider Cow
CNBC View CYCC Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYCC - OTC Markets
Yahoo View Insider Transactions for CYCC - Yahoo! Finance NASDAQ View Institutional Holdings for CYCC - NASDAQ

Stock Charts

FinViz View CYCC Stock Insight & Charts - StockCharts View CYCC Investment Charts -
BarChart View CYCC Stock Overview & Charts - BarChart Trading View View CYCC User Generated Charts - Trading View

Latest Financial News for CYCC

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results
Posted on Wednesday March 21, 2018

BERKELEY HEIGHTS, N.J., March 21, 2018-- Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of ...

Consolidated Research: 2018 Summary Expectations for Triangle Capital, Federal Agricultural Mortgage, Cyclacel Pharmaceuticals, Sterling Construction, Select Energy Services, and Citi Trends — Fundamental Analysis, Key Performance Indications
Posted on Tuesday March 20, 2018

NEW YORK, March 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

Phase 1 Clinical Data With Cyclacel’s CYC065 CDK Inhibitor Have Been Selected for Oral Presentation at AACR 2018 Annual Meeting
Posted on Thursday March 15, 2018

BERKELEY HEIGHTS, N.J., March 15, 2018-- Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of ...

Cyclacel Pharmaceuticals to Present at the 30th Annual ROTH Conference
Posted on Tuesday March 06, 2018

BERKELEY HEIGHTS, N.J., March 06, 2018-- Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage response biology to develop ...

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.